Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer. The company is based in New Haven, Connecticut.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Phone203-787-7888
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.72 million
Profitability
Miscellaneous
Employees33
OptionableNot Optionable
Precipio (NASDAQ:PRPO) Frequently Asked Questions
What is Precipio's stock symbol?
Precipio trades on the NASDAQ under the ticker symbol "PRPO."
When did Precipio's stock split? How did Precipio's stock split work?
Shares of Precipio reverse split on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 5th 2017. An investor that had 100 shares of Precipio stock prior to the reverse split would have 3 shares after the split.
How were Precipio's earnings last quarter?
Precipio Inc (NASDAQ:PRPO) announced its quarterly earnings results on Monday, November, 19th. The biotechnology company reported ($0.13) earnings per share for the quarter. The biotechnology company earned $0.65 million during the quarter. Precipio had a negative net margin of 610.39% and a negative return on equity of 149.24%. View Precipio's Earnings History.
When is Precipio's next earnings date?
Has Precipio been receiving favorable news coverage?
News coverage about PRPO stock has trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Precipio earned a news sentiment score of -1.4 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days.
Who are some of Precipio's key competitors?
Some companies that are related to Precipio include Illumina (ILMN), Agilent Technologies (A), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).
Who are Precipio's key executives?
Precipio's management team includes the folowing people:
- Mr. Ilan Danieli, Founder, Pres, CEO & Director (Age 46)
- Mr. Carl R. Iberger, CFO & Sec. (Age 65)
- Mr. Ahmed Zaki Sabet, Chief Operating Officer (Age 32)
- Mr. Douglas Sites, VP of Sales
- Mr. Ayman Mohamed, Sr. VP of R&D and Laboratory Operations (Age 33)
How do I buy shares of Precipio?
Shares of PRPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Precipio's stock price today?
One share of PRPO stock can currently be purchased for approximately $0.2041.
How big of a company is Precipio?
Precipio has a market capitalization of $6.20 million and generates $1.72 million in revenue each year. Precipio employs 33 workers across the globe.
What is Precipio's official website?
How can I contact Precipio?
Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The biotechnology company can be reached via phone at 203-787-7888 or via email at [email protected]
MarketBeat Community Rating for Precipio (NASDAQ PRPO)
MarketBeat's community ratings are surveys of what our community members think about Precipio and other stocks. Vote "Outperform" if you believe PRPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
